Modulation of key regulators of mitosis linked to chromosomal instability is an early event in ochratoxin A carcinogenicity

被引:55
作者
Adler, Melanie [1 ]
Mueller, Katja [1 ]
Rached, Eva [1 ]
Dekant, Wolfgang [1 ]
Mally, Angela [1 ]
机构
[1] Univ Wurzburg, Dept Toxicol, D-97078 Wurzburg, Germany
关键词
TOPOISOMERASE-II-ALPHA; GENE-EXPRESSION PROFILES; MITOTIC CHECKPOINT GENES; AURORA-B OVEREXPRESSION; TUMOR-SUPPRESSOR GENE; RENAL-CELL CARCINOMAS; DNA-DAMAGE; HUMAN KIDNEY; CANCER; APOPTOSIS;
D O I
10.1093/carcin/bgp049
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Ochratoxin A (OTA) is a potent renal carcinogen, but little is known regarding the mechanism of OTA carcinogenicity. Early histopathological alterations induced by OTA in rat kidney include single cell death, stimulation of cell proliferation and prominent karyomegaly indicative of blocked nuclear division during mitosis. Based on these observations, it has been suggested that disruption of mitosis by OTA may be the principal cause of cell death and subsequent trigger for cell proliferation to compensate for cell loss. To gain further insight into the molecular mechanism of OTA toxicity, we used targeted quantitative real-time polymerase chain reaction arrays to investigate the expression of genes involved in cell cycle control and mitosis in kidneys of male F344 rats treated with 0, 21, 70 and 210 mu g/kg body wt OTA for up to 90 days. Treatment with OTA resulted in overexpression of key regulators of mitosis, including the mitotic protein kinases Polo-like kinase 1, Aurora B and cyclin-dependent kinase 1 (Cdk1(Cdc2)), several cyclins and cyclin-dependent kinase inhibitors, topoisomerase II and survivin. Immunohistochemical analysis confirmed upregulation of Cdk1, p21(WAF1/CIP1), topoisomerase II and survivin in S3 proximal tubule cells, from which OTA-induced tumors in rats arise, and demonstrated increased phosphorylation of histone H3, a target of Aurora B. Importantly, many of the genes found to be deregulated in response to OTA have been linked to chromosomal instability and malignant transformation, supporting the hypothesis that aberrant mitosis, resulting in blocked or asymmetric cell division, accompanied by an increased risk of aneuploidy acquisition, may play a critical role in OTA carcinogenicity.
引用
收藏
页码:711 / 719
页数:9
相关论文
共 66 条
[1]   CDK inhibitors: Cell cycle regulators and beyond [J].
Besson, Arnaud ;
Dowdy, Steven F. ;
Roberts, James M. .
DEVELOPMENTAL CELL, 2008, 14 (02) :159-169
[2]   The spindle checkpoint, aneuploidy, and cancer [J].
Bharadwaj, R ;
Yu, HT .
ONCOGENE, 2004, 23 (11) :2016-2027
[3]   RENAL LESIONS INDUCED BY OCHRATOXIN-A EXPOSURE IN THE F344 RAT [J].
BOORMAN, GA ;
MCDONALD, MR ;
IMOTO, S ;
PERSING, R .
TOXICOLOGIC PATHOLOGY, 1992, 20 (02) :236-245
[4]   Subcellular localization of the spindle proteins Aurora A, Mad2, and BUBR1 assessed by immunohistochemistry [J].
Burum-Auensen, Espen ;
De Angelis, Paula M. ;
Schjolberg, Aasa R. ;
Kravik, Katherine L. ;
Aure, Marit ;
Clausen, Ole Petter F. .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2007, 55 (05) :477-486
[5]   A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers [J].
Carter, Scott L. ;
Eklund, Aron C. ;
Kohane, Isaac S. ;
Harris, Lyndsay N. ;
Szallasi, Zoltan .
NATURE GENETICS, 2006, 38 (09) :1043-1048
[6]   Cell death by mitotic catastrophe: a molecular definition [J].
Castedo, M ;
Perfettini, JL ;
Roumie, T ;
Andreau, K ;
Medema, R ;
Kroemer, G .
ONCOGENE, 2004, 23 (16) :2825-2837
[7]   p21Waf1/Cip1/Sdi1-induced growth arrest is associated with depletion of mitosis-control proteins and leads to abnormal mitosis and endoreduplication in recovering cells [J].
Chang, BD ;
Broude, EV ;
Fang, J ;
Kalinichenko, TV ;
Abdryashitov, R ;
Poole, JC ;
Roninson, IB .
ONCOGENE, 2000, 19 (17) :2165-2170
[8]   Disruption of gap junctions in toxicity and carcinogenicity [J].
Chipman, JK ;
Mally, A ;
Edwards, GO .
TOXICOLOGICAL SCIENCES, 2003, 71 (02) :146-153
[9]   Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures [J].
Degen, GH ;
Gerber, MM ;
ObrechtPflumio, S ;
Dirheimer, G .
ARCHIVES OF TOXICOLOGY, 1997, 71 (06) :365-371
[10]   Ochratoxin A: Comparative pharmacokinetics and toxicological implications (experimental and domestic animals and humans) [J].
Dietrich, DR ;
Heussner, AH ;
O'Brien, E .
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT, 2005, 22 :45-52